Adverse systemic effects from topical eye drugs.
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001285:Atropine / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D003345:Corticosterone; D003480:Cushing Syndrome / Q000139:chemically induced; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D010276:Parasympatholytics / Q000009:adverse effects; D010277:Parasympathomimetics / Q000009:adverse effects; D012601:Scopolamine / Q000009:adverse effects; D014326:Tropanes / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D002800:Cholinesterase Inhibitors; D009883:Ophthalmic Solutions; D010276:Parasympatholytics; D010277:Parasympathomimetics; D014326:Tropanes; D001285:Atropine; D012601:Scopolamine; D003345:Corticosterone